Novavax, Inc.

(NASDAQ:NVAX)

1.79

-0.13 (-6.77%)

Jan 09 - Close

Open
1.91
High
1.93
Low
1.79
Vol.
145.35K
Mkt Cap
132.81M
52Wk High
3.71
52Wk Low
1.22
Avg. Vol.
137.20K
P/E (Trailing)
-3.25
Beta
0.00
Short %
4.80%
Div. Yield
—

After-Hours 1.80 +0.01 (0.56%) Fri, 9 Jan 2009 7:40 PM

Company Profile

Novavax, Inc.

9920 Belward Campus Drive

Rockville, MD 20850

United States - Map

Phone: (240) 268-2000

Fax: (484) 931-0150

Website: www.novavax.com

State of incorporation: Delaware

CEO: Dr. Rahul Singhvi

Employees: 84

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

Dev proprietary organized lipid structures

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.

Recent news for NVAX

Members owning NVAX also own

WIN (100.00%), TC (100.00%), V (100.00%), WEL (100.00%), IPI (100.00%)

Member sentiment (?)    Neutral

- MarketGuru Blog network-

Top members owning NVAX

* Average monthly return vs. S&P 500

Recent opinions on NVAX

No recent Opinions for NVAX